Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

44.44
Delayed Data
As of Jun 23
 +0.77 / +1.76%
Today’s Change
30.89
Today|||52-Week Range
57.41
+23.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues4.1B4.1B4.3B4.1B
 
 
 
 
 
Cost of Goods Sold502.4M488.5M547.2M510.3M
 
 
 
 
 
Depreciation And Amortization108.2M110.6M160.6M102.0M
 
 
 
 
 
 
Operating ExpensesGross Income3.5B3.5B3.5B3.5B
 
 
 
 
 
General Expenses1.7B1.7B1.9B1.6B
 
 
 
 
 
Research And Development502.8M519.7M643.4M473.7M
 
 
 
 
 
Total Operating Expenses2.3B2.3B2.7B2.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.9B1.8B1.6B1.9B
 
 
 
 
 
Interest Expense On Debt14.9M--35.0M2.6M
 
 
 
 
Other Expenses40.0M12.5M10.9M-27.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.9B1.8B1.6B1.9B
 
 
 
 
 
Income Taxes-397.6M-375.4M-322.8M-410.2M
 
 
 
 
 
Net Income1.5B1.5B1.3B1.5B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.59$0.58$0.50$0.59
 
 
 
 
 
EPS Diluted$0.59$0.58$0.50$0.58